Skip to main content

OPEN ACCESS: Sub-Visible and Sub-Micrometer Particles in Biopharmaceutical Development

Thank you

This live web event has ended. Thank you for attending.


  • Dr. Atanas Koulov, Head Drug Product Analytical Development and Quality Control

    Atanas Koulov has extensive experience in drug product analytical development and quality control release and stability testing, as well as characterization, investigations support and specification setting. His eight years of industry experience include managing Roche’s Particle lab, activities for visible, subvisible and submicron particles as well as responsibility for various programs in Analytical Development & QC of Drug Products. Prior to joining Roche, Atanas also worked as a Lab Head, Analytical Development at Novartis Biologics.

    Atanas has published extensively in the field of protein aggregation and particles and is the immediate past chair of the AAPS Protein Aggregation & Biological Consequences Focus Group. He holds a Ph.D. in Biochemistry from the University of Notre Dame, IN (USA), earned his M.Sc. in Molecular Biology and Clinical Chemistry from Sofia University (BG) and worked as Postdoctoral Fellow at the Scripps Research Institute in San Diego, CA (USA).

April 5, 2017
Wed 12:30 PM EDT

Duration 1H 30M

This live web event has ended.